Boundless Bio, Inc. BOLD
2.66
0.06
2.31%
as of 25 Sep
- Market cap
- $59.1M
- P/E
- 0.0×
Follow BOLD
Insider Buys
alert about insiders buying in the last 12 month
| Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|
Current Ratio |
8.80 | 13.27 | 18.98 | 8.74 |
Net Debt/EBITDA |
1.40 | 2.24 | 1.45 | 0.99 |
Debt/Assets |
3.70% | 0.00% | 23.08% | 29.20% |
Debt/Equity |
0.04 | 0.00 | 0.32 | 0.46 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.86 | 0.95 | 0.93 | 0.80 |
Capex/Depreciation |
(1.13) | (0.66) | (2.34) | (0.44) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 |
| 0.00% | 47.36% | (554.86%) | (46.69%) | |
| 0.00% | (47.83%) | (38.87%) | (32.02%) | |
ROIC |
(1,221.33%) | 0.00% | (99.20%) | (107.52%) |
Return on Tangible Assets |
(72.59%) | (42.10%) | (43.41%) | (58.03%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(37.03) | (39.05) | (3.73) | (2.11) |
Cash per Share |
60.76 | 99.30 | 8.96 | 4.81 |
Shareholders Equity per Share |
60.34 | 99.12 | 8.87 | 4.41 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
60.34 | 99.12 | 8.87 | 4.41 |
Free Cash Flow |
(40.66) | (47.49) | (63.38) | (47.21) |
Working Capital |
60.31 | 114.85 | 146.26 | 97.07 |
Capital Expenditures |
(1.07) | (0.63) | (2.54) | (0.55) |
Net Current Asset Value |
57.46 | 114.85 | 98.62 | 51.21 |
| Other line items | ||||
Quick Ratio |
8.63 | 12.90 | 18.70 | 8.58 |
Depreciation/Fixed assets |
0.32 | 0.37 | 0.25 | 0.39 |
Cash ROIC |
(31.31%) | (20.49%) | (18.60%) | (19.78%) |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(36.06) | (38.53) | (3.58) | (2.09) |
Capex per Share |
(0.97) | (0.52) | (0.15) | (0.02) |
Average Payables |
— | 3.55 | 4.81 | 6.04 |
Average Assets |
— | 103.36 | 168.15 | 181.73 |
Average Common Equity |
— | (104.39) | 11.78 | 124.65 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates